Ruowen Zhang

Marine Biomedical Research Institute of Qingdao

Also affiliated with Inotek Pharmaceuticals (United States), Beihang University

MedicinePharmacology, Toxicology and PharmaceuticsBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “GLI1: A Therapeutic Target for Cancer”.

GLI1: A Therapeutic Target for Cancer

Frontiers in Oncology(2021)10.3389/fonc.2021.673154

N/A

0.704DataRank · unranked

108 citations

Ruowen Zhang, Rebecca J. Boohaker, Justin Avery

GLI1 Inhibitor SRI-38832 Attenuates Chemotherapeutic Resistance by Downregulating NBS1 Transcription in BRAFV600E Colorectal Cancer

Frontiers in Oncology(2020)10.3389/fonc.2020.00241

N/A

0.449DataRank · unranked

19 citations

Jinlu Ma, Justin Avery, Vijaya Sambandam, Theresa Nguyen, Bo Xu +3 more

Attenuating iPSC reprogramming stress with dominant-negative BET peptides

iScience(2022)10.1016/j.isci.2022.105889

N/A

0DataRank · unranked

1 citations

Ricardo R. Cevallos, Ruowen Zhang, Kejin Hu, Md Emon Hossain

BRD2 impedes iPSC reprogramming by regulating lipogenesis and matrisome

Research Square(2025)10.21203/rs.3.rs-7744310/v1

N/A

0DataRank · unranked

0 citations

Ricardo R. Cevallos, Ruowen Zhang, S. Chen, Kejin Hu